• LAST PRICE
    1.0700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.9200/ 1
  • Ask / Lots
    1.1900/ 1
  • Open / Previous Close
    0.0000 / 1.0700
  • Day Range
    ---
  • 52 Week Range
    Low 0.8940
    High 5.9399
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.09
TimeVolumePOAI
09:32 ET39621.09
09:45 ET15001.1
09:56 ET6241.06
09:57 ET8831.06
09:59 ET2851.06
10:03 ET1901.05
10:10 ET11891.03
10:15 ET1001.06
10:17 ET10001.045
10:19 ET20971.03
10:24 ET10001.035
10:30 ET1001.04
10:39 ET57001.045
10:42 ET11001.0452
10:44 ET5001.0639
10:46 ET4401.05
10:50 ET28831.06
10:51 ET1181.07
11:02 ET1501.06
11:09 ET3001.07
11:13 ET10001.065
11:18 ET4001.06
11:27 ET14011.0695
11:31 ET1001.06
11:58 ET32001.06
12:07 ET42501.055
12:20 ET1501.06
12:50 ET14211.05
12:59 ET7851.0401
01:03 ET1311.0489
02:13 ET1711.04
03:12 ET3001.05
03:20 ET25191.06
03:23 ET1001.084
03:27 ET2001.076
03:32 ET5001.07
03:39 ET1001.076
03:41 ET1301.07
03:43 ET2001.07
03:45 ET1111.07
03:52 ET2001.075
03:59 ET4681.07
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPOAI
Predictive Oncology Inc
4.8M
-0.3x
---
United StatesPBIO
Pressure Biosciences Inc
4.2M
0.0x
---
United StatesRSCF
Reflect Scientific Inc
4.7M
-13.6x
---
United StatesSINT
SINTX Technologies Inc
3.9M
0.0x
---
United StatesNUMD
Nu-Med Plus Inc
4.7M
-50.0x
---
United StatesDROR
Dror Ortho-Design Inc
4.4M
-0.8x
---
As of 2024-07-23

Company Information

Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.

Contact Information

Headquarters
91 43RD STREET, SUITE 110PITTSBURGH, PA, United States 15201
Phone
412-432-1500
Fax
651-379-5024

Executives

Chairman of the Board, Chief Executive Officer
Raymond Vennare
Interim Chief Financial Officer
Josh Blacher
Lead Independent Director
Chuck Nuzum
Independent Director
Nancy Chung-Welch
Independent Director
Daniel Handley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.8M
Revenue (TTM)
$2.0M
Shares Outstanding
4.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.17
EPS
$-3.66
Book Value
$2.04
P/E Ratio
-0.3x
Price/Sales (TTM)
2.4
Price/Cash Flow (TTM)
---
Operating Margin
-758.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.